SUPERNUS PHARMACEUTICALS INC (SUPN)

US8684591089 - Common Stock

30.83  +0.56 (+1.85%)

After market: 30.83 0 (0%)

Buy % Consensus

82

ChartMill assigns a Buy % Consensus number of 82% to SUPN. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 41.31. This target is 33.99% above the current price.
SUPN was analyzed by 10 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about SUPN.
In the previous month the buy percentage consensus was at a similar level.
SUPN was analyzed by 10 analysts. More opinions would make the average more meaningful.

Price Target & Forecast

Price Low Median Mean High 30.8338.3841.3141.3145.15 - 24.49% 33.99% 33.99% 46.45%
Up and Down Grades
Date Firm Action Rating
2024-02-28 Piper Sandler Maintains Overweight -> Overweight
2023-11-09 Piper Sandler Maintains Overweight -> Overweight
2023-10-25 Piper Sandler Maintains Overweight -> Overweight
2023-05-10 Piper Sandler Maintains Overweight -> Overweight
2023-01-23 Piper Sandler Maintains Overweight
2022-08-31 Piper Sandler Maintains Overweight
2021-04-13 Jefferies Upgrade Hold -> Buy